ADM and hydrops fetalis: However, since an increased plasma level of biologically active ADM (bio-ADM), correlates with a high mortality risk, whilst its plasma level normalization, correlates with a decrease in mortality (39), it becomes a controversial subject of whether supplemental administration of ADM would really be beneficial among HF patients.